Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
0.7854
-0.0143 (-1.79%)
At close: Jul 16, 2025, 4:00 PM
0.7640
-0.0214 (-2.72%)
After-hours: Jul 16, 2025, 7:50 PM EDT
Advanced Biomed Market Cap
Advanced Biomed has a market cap or net worth of $17.00 million as of July 16, 2025.
Market Cap
17.00M
Enterprise Value
13.02M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since the IPO on March 6, 2025, Advanced Biomed's market cap has decreased from $87.50M to $17.00M, a decrease of -80.58%. That is a compound annual growth rate of -98.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 17.31M | -0.04% |
| Jul 14, 2025 | 17.31M | 6.38% |
| Jul 11, 2025 | 16.27M | -4.23% |
| Jul 10, 2025 | 16.99M | 16.98% |
| Jul 9, 2025 | 14.53M | 1.40% |
| Jul 8, 2025 | 14.33M | -0.30% |
| Jul 7, 2025 | 14.37M | -2.50% |
| Jul 3, 2025 | 14.74M | -2.71% |
| Jul 2, 2025 | 15.15M | -3.32% |
| Jul 1, 2025 | 15.67M | 3.43% |
| Jun 30, 2025 | 15.15M | -1.41% |
| Jun 27, 2025 | 15.36M | 11.67% |
| Jun 26, 2025 | 13.76M | -6.50% |
| Jun 25, 2025 | 14.72M | -8.41% |
| Jun 24, 2025 | 16.07M | 3.11% |
| Jun 23, 2025 | 15.58M | 3.90% |
| Jun 20, 2025 | 15.00M | -10.59% |
| Jun 18, 2025 | 16.77M | -7.06% |
| Jun 17, 2025 | 18.05M | -9.57% |
| Jun 16, 2025 | 19.96M | -3.92% |
| Jun 13, 2025 | 20.77M | 0.19% |
| Jun 12, 2025 | 20.73M | 0.85% |
| Jun 11, 2025 | 20.56M | 2.04% |
| Jun 10, 2025 | 20.15M | 0.28% |
| Jun 9, 2025 | 20.09M | -1.23% |
| Jun 6, 2025 | 20.34M | 1.02% |
| Jun 5, 2025 | 20.14M | -2.97% |
| Jun 4, 2025 | 20.75M | -4.10% |
| Jun 3, 2025 | 21.64M | 5.26% |
| Jun 2, 2025 | 20.56M | -7.76% |
| May 30, 2025 | 22.29M | -7.22% |
| May 29, 2025 | 24.02M | -4.32% |
| May 28, 2025 | 25.10M | -3.33% |
| May 27, 2025 | 25.97M | 5.26% |
| May 23, 2025 | 24.67M | -4.20% |
| May 22, 2025 | 25.75M | 0.85% |
| May 21, 2025 | 25.54M | -1.74% |
| May 20, 2025 | 25.99M | -3.93% |
| May 19, 2025 | 27.05M | -1.57% |
| May 16, 2025 | 27.48M | 9.48% |
| May 15, 2025 | 25.10M | -2.52% |
| May 14, 2025 | 25.75M | 16.67% |
| May 13, 2025 | 22.07M | 13.90% |
| May 12, 2025 | 19.38M | -5.63% |
| May 9, 2025 | 20.53M | -11.32% |
| May 8, 2025 | 23.15M | -35.16% |
| May 7, 2025 | 35.71M | -13.61% |
| May 6, 2025 | 41.33M | -7.73% |
| May 5, 2025 | 44.79M | 6.15% |
| May 2, 2025 | 42.20M | 2.09% |
| May 1, 2025 | 41.33M | -0.55% |
| Apr 30, 2025 | 41.56M | -3.98% |
| Apr 29, 2025 | 43.28M | 0.01% |
| Apr 28, 2025 | 43.28M | 10.50% |
| Apr 25, 2025 | 39.17M | -2.69% |
| Apr 24, 2025 | 40.25M | -2.11% |
| Apr 23, 2025 | 41.12M | 7.34% |
| Apr 22, 2025 | 38.30M | 5.99% |
| Apr 21, 2025 | 36.14M | -7.73% |
| Apr 17, 2025 | 39.17M | -5.73% |
| Apr 16, 2025 | 41.55M | 1.05% |
| Apr 15, 2025 | 41.12M | 3.83% |
| Apr 14, 2025 | 39.60M | 7.02% |
| Apr 11, 2025 | 37.00M | -5.00% |
| Apr 10, 2025 | 38.95M | -8.86% |
| Apr 9, 2025 | 42.74M | 9.12% |
| Apr 8, 2025 | 39.17M | -37.59% |
| Apr 7, 2025 | 62.76M | -13.69% |
| Apr 4, 2025 | 72.71M | -3.72% |
| Apr 3, 2025 | 75.52M | -4.90% |
| Apr 2, 2025 | 79.42M | -4.13% |
| Apr 1, 2025 | 82.84M | -2.34% |
| Mar 31, 2025 | 84.83M | -2.00% |
| Mar 28, 2025 | 86.56M | 0.76% |
| Mar 27, 2025 | 85.91M | 0.25% |
| Mar 26, 2025 | 85.69M | 1.80% |
| Mar 25, 2025 | 84.18M | -0.26% |
| Mar 24, 2025 | 84.40M | 1.57% |
| Mar 21, 2025 | 83.10M | 4.35% |
| Mar 20, 2025 | 79.64M | 0.55% |
| Mar 19, 2025 | 79.20M | 0.27% |
| Mar 18, 2025 | 78.99M | -6.17% |
| Mar 17, 2025 | 84.18M | 2.91% |
| Mar 14, 2025 | 81.80M | 7.08% |
| Mar 13, 2025 | 76.39M | -5.60% |
| Mar 12, 2025 | 80.92M | -1.59% |
| Mar 11, 2025 | 82.23M | 8.14% |
| Mar 10, 2025 | 76.05M | -3.72% |
| Mar 7, 2025 | 78.99M | -9.73% |
| Mar 6, 2025 | 87.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.83B |
| Johnson & Johnson | 373.35B |
| AbbVie | 329.24B |
| Novo Nordisk | 299.09B |
| UnitedHealth Group | 264.62B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 228.77B |
| AstraZeneca | 217.99B |